most popular glp-1 drugs List of approved and pending medications GLP-1 drugs, which have grown
Description
Includes PREDIMED data and EU health claim context.
The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease
Intention-to-treat analyses resulted in an HR of 1.36 (95% CI 0.51, 3.61)
95% CI 0.90, 1.01) and cerebrovascular events (HR 0.99
